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Abstract
The motor protein prestin is a member of the SLC26 family of anion antiporters and is essen-
tial to the electromotility of cochlear outer hair cells and for hearing. The only direct inhibitor
of electromotility and the associated charge transfer is salicylate, possibly through direct
interaction with an anion-binding site on prestin. In a screen to identify other inhibitors of
prestin activity, we explored the effect of the non-steroid anti-inflammatory drug diflunisal,
which is a derivative of salicylate. We recorded prestin activity by whole-cell patch clamping
HEK cells transiently expressing prestin and mouse outer hair cells. We monitored the
impact of diflunisal on the prestin-dependent non-linear capacitance and electromotility. We
found that diflunisal triggers two prestin-associated effects: a chloride independent increase
in the surface area and the specific capacitance of the membrane, and a chloride dependent
inhibition of the charge transfer and the electromotility in outer hair cells. We conclude that
diflunisal affects the cell membrane organization and inhibits prestin-associated charge
transfer and electromotility at physiological chloride concentrations. The inhibitory effects on
hair cell function are noteworthy given the proposed use of diflunisal to treat neurodegenera-
tive diseases.
Introduction
The cylindrically shaped, polarized epithelial cochlea outer hair cells (OHC) respond to changes
in membrane potential. Hyperpolarization of the membrane voltage triggers an elongation of
the OHC while depolarization triggers cell shortening [1,2]. This voltage-dependent motility
enhances sound amplification in the cochlea [1] and the electromotility motor has been identi-
fied as the transmembrane protein prestin (SLC26A5) [3]. When present in the cytoplasmic
membrane, prestin converts changes in the electrical field into mechanical force, without the
use of ATP, calcium or any identified cytoskeletal protein [4]. OHC electromotility is associated
with a nonlinear voltage-to-capacitance relationship that can be fitted to a two-state Boltzmann
function. This non-linear capacitance (NLC) reflects the voltage-dependent charge movement
that occurs within the membrane and is used to monitor prestin activity [3,5,6]. Despite an
essential role in voltage sensing, the biophysical basis of the charge movement is uncertain. In
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the intrinsic voltage sensor model, the voltage-sensing depends on the movement of charged
amino acids [7] while in the extrinsic voltage sensor model, intracellular anions such as chloride
translocate through prestin in response to voltage [4]. Regardless, the modulation of the charge
movement and of OHC electromotility by anions [4,8,9] supports the existence of a monova-
lent-anion binding site in prestin [4,7,10].
The only direct inhibitor of prestin function is salicylate, which inhibits the charge move-
ment and the associated electromotility, putatively by competing with chloride for the anion-
binding site in prestin [4,7,11]. By contrast, temperature [12], intracellular pressure [13], or
molecules like cholesterol [14–16], chlorpromazine [17–19] and lipophilic ions [20] are hypo-
thesized to trigger changes in membrane properties (curvature, thickness and mechanics) that
result in modifications of prestin function. Changes in lipid-bilayer properties have been asso-
ciated with the modulation of many membrane proteins [21].
In order to understand the physiological consequences of prestin modulation, we aimed at
identifying more direct effectors and inhibitors of prestin activity. Based on the effective inhi-
bition of salicylate, we have investigated the effect of the salicylate-derivative diflunisal (DFL)
on mouse OHCs and on HEKs expressing prestin[14,15,22,23]. DFL was discovered in the
1980’s to have improved lipophilicity, increased anti-inflammatory and analgesic properties
over salicylate [24]. Interestingly, diflunisal prevents amyloid fibril formation in vitro, and is
being investigated as a treatment for familial amyloid polyneuropathy, a multisystem disorder
resulting from the deposition of fibril aggregates in tissues [25–27].
Materials and methods
The HEK 293 model system, validated for electrophysiological studies of prestin activities
[15,28,29], is used to monitor prestin function after presentation of NSAIDs. The effect of
chloride on the inhibition of prestin by DFL and the resulting impact on electromotility are
further investigated using OHCs.
Cell culture
Stable HEKs 293 expressing prestin [22] were grown at 37˚C with 5% CO2 in DMEM (Cellgro)
complemented with 10% Tet-System Approved FBS (Clontech) in the presence of penicillin,
streptomycin, G418 and hygromycin (Invitrogen). Doxycycline (Clontech) was added to the
growing media at a final concentration of 2 μg/ml to induce the expression of prestin-mGFP.
The stable cell line expressing prestin was constructed as described previously [22].
Electrophysiology and capacitance recordings
Pipettes were pulled from borosilicate capillary tubes 0.8–1.1 x 100mm (Kimble Chase- for
HEKs) or Thin Wall Patch Glass (Warner Instrument–for OHCs) to obtain 2.5 to 3.5 MO
openings. The electrophysiology was performed using an EPC10 plus amplifier (HEKA). The
intracellular blocking solution (ICB) contains 130 mM CsCl, 2 mM MgCl2,10 mM EGTA and
10 mM HEPES. For low chloride experiment, the chloride was replaced by glutamate. The
bath blocking solution (ECB) contains 99 mM NaCl, 20 mM TEA- Cl, 2 mM CoCl2, 1.47 mM
MgCl2, 1 mM CaCl2, 10 mM HEPES. These solutions are both titrated to pH 7.2, and osmo-
adjusted with dextrose to 320 mosM for HEKs and 300 mosM for OHCs. Only healthy, single
HEK cells showing suitable GFP fluorescence were assayed. OHCs were used within 4 hours of
animal death, and within 1 hour of being in the recording chamber at RT. All cells retained for
analysis exhibited series resistance less than 10 MO and membrane resistance in excess of 1
GO for HEKs and 300MO for OHCs. The intracellular pressure was controlled with a High-
Speed Pressure Clamp (ALA). The membrane capacitance (Cm) was determined using a
Diflunisal inhibits prestin
PLOS ONE | https://doi.org/10.1371/journal.pone.0183046 August 17, 2017 2 / 16
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phase-sensitive detector implemented in PatchMaster (HEKA) as described elsewhere [23].
Briefly, we applied an 800-Hz, 10-mV sine wave and measured the current response as DC
holding potential was stepped in 2 mV increments (0.4mV/ms). The phase shift monitored
between the output and the input signals allows for determination of the membrane capaci-
tance. The resulting capacitance versus voltage curve is fitted to the first derivative of the two-
state Boltzmann function:
Cm ¼
Qmax zekT
  
exp zekT ðV   V1=2
 
 1þ exp zekT ðV   V1=2Þ
  2 þ Clin ð1Þ
Qmax is the maximum nonlinear electric charge movement provided by all active prestin
during transition, V1/2 is the voltage at which half-maximal charge transfer occurs and z is
the valence of charge movement. Clin is the linear capacitance. Since variation in cell size
causes differences in the maximal charge transfer Qmax, the charge movement is normalized to
Clin. This parameter, designated as “charge density” can be interpreted as a quantitative mea-
sure of the amount of functional prestin in the membrane. The NLC yielded by the stable HEK
cell-line used here averaged the following parameters (value ±SD): z = 0.79 ± 0.12; V1/2 =
-68.56 ± 18.18 mV; Clin = 20.9 ± 8.7 pF; Qmax = 0.13 ± 0.1 pC; CD (Qmax/Clin) = 6.30 ± 3.30
fC/pF.
NLCs obtained from OHCs were fitted using the two-state CSA model equation [29]:
Cm ¼
Qmax zekT
  
exp zekT ðV   V1=2
 
 1þ exp zekT ðV   V1=2Þ
  2 þ
DCSA
1þ exp zekT ðV   V1=2Þ
    1
þ Clin ð2Þ
For each cell successfully patched, three NLC curve were collected per condition tested and
the parameters of the fits were averaged. Each experimental condition was tested 3 times or
more on independent cells. The average values and standard deviation reported in the results
were calculated based on these independent measurements.
Diflunisal application
The diflunisal was from Sigma Aldrich. Solutions were made on the same day as the experi-
ment in ECB before adjusting the pH and the osmolarity. The buffer in the recording cham-
bers (~400 μL) was exchanged with 4 mL of DFL solution, using a gravity-driven perfusion
system (~ 2 mL/min). This was followed by an incubation of 2 minutes. Chemicalize.org was
used for pKa, logP and logD predictions [30]. The effect of perfusion alone was determined by
measuring the changes occurring upon perfusion of clean extracellular buffer or buffer con-
taining a higher NaCl concentration (an extra 10 mM, yielding a total 109 mM in the ECB).
No significant impact on the NLC parameters was observed with these control experiments
(S1 Fig).
OHC isolation
One to 2 month old C57BL/6 mice were euthanized by CO2 asphyxiation, decapitated and dis-
sected immediately. The cochlea was then separated from the temporal bone in ECB and cut
in half. Each part was individually incubated in collagenase 0.5 mg/mL in ECB for 20 minutes
at 37˚C to dissociate the cells. The samples were then kept on ice until use. At the time of trans-
fer to the electrophysiology chamber, the OHCs were further dissociated by gentle pipetting.
Selected cells had a uniform cylindrical shape with a basally located nucleus and were used
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within 4 hours post-mortem. The Institutional Animal Care and Use Committee of Rice Uni-
versity and Baylor College of Medicine approved all experiments and procedures involving
animals.
Electromotility
Images were acquired with μmanager [31] controlling a a Retiga 2000R camera (Q-imaging),
using a 63X objective on an Axiovert 200 microscope (Zeiss). Mice OHCs were imaged at 50
fps at a definition of 5.5 pixels/μm. The membrane surface area was calculated from the cell
diameter, measured at the nucleus level, and the cell length, measured between the base and
the apex (average A = 623±100 μm2 for n = 34 cells). Cell movement was analyzed with Video
Spot Tracker (CCISMM), with trackers positioned at the base and the apex of the OHC. The
distance between the base and the apex of the cell was plotted against the applied voltage. The
resulting curve was fitted to a two-state Boltzmann equation:
L ¼
Lmax
1þ expð  aðV   V1=2ÞÞ
þ L0 ð3Þ
Results
Effect of diflunisal on prestin in HEKs
The preliminary explorations of diflunisal (DFL) involved recording non-linear capacitance
(NLC) in HEKs expressing prestin. For each cell, the NLC is recorded in the absence and in
the presence of extracellular DFL and each NLC curve is fitted to Eq 1 (Fig 1A). DFL signifi-
cantly affects all the measured parameters of the prestin-induced NLC. The V1/2 and charge
density (Qmax/Clin) are decreased by a DFL concentration as low as 100 μM and reaches signif-
icance above 500 μM. At 4 mM, the charge density is decreased by more than 50% and V1/2 is
shifted by almost 70mV toward depolarized potentials. The apparent charge valence z is only
significantly affected in the presence of 4 mM DFL (+11±4%). Additionally, the linear capaci-
tance Clin is increased by 5.3±1.7% at 0.5 mM and 10±4% at 2 mM, suggesting an effect of DFL
on the membrane thickness or the dielectric constant. This could indicate partitioning of the
molecules in the membrane despite the weak lipophilicity of DFL (logDpH 7.2 = 1 [30]). For
this reason, the effect of DFL on the membrane specific capacitance CM was further investi-
gated in HEKs without prestin (Fig 1B and 1C). The membrane capacitance is increased in the
presence of 0.5 and 1 mM DFL to a similar extend as Clin is in HEKs with prestin. In the
absence of prestin, DFL did not cause any voltage-dependent fluctuation of the capacitance
between –200mV to +200 mV. We observe an almost full reversibility of the DFL-induced
effect on the membrane or on prestin after washout of DFL with extracellular buffer (ECB).
The partial inhibition of the charge transfer observed in HEKs encourages a more thorough
investigation of the effect of DFL on prestin and on the outer hair cells (OHCs).
Effect of DFL on outer hair cell function
We investigated the effect of DFL on OHCs that express endogenous prestin. Due to the re-
ported prestin-salicylate sensitivity to chloride concentrations [32], we investigated the impact
that high (140 mM) and low (5 mM) chloride concentrations have on the DFL inhibition of
prestin. The effect of DFL on the NLC is similar to that described with HEK recordings (Fig 1)
where the peak voltage is shifted to depolarizing potentials, the amplitude lowered and Clin
increased (Fig 2A). We also tracked the motility of the OHCs in response to voltage. Consistent
Diflunisal inhibits prestin
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with the shift in NLC and the increase in Clin, the electromotility (eM) curve is shifted to depo-
larized voltages and the total length of the cell is increased by DFL (Fig 2C). However, no
apparent effect was noted on the amplitude of eM in high chloride conditions at the DFL con-
centration tested. DFL concentrations above 1mM weakened the pipette-OHC seal and could
not be accurately assessed. However, lowering the chloride concentration enhanced the effect
of the DFL on prestin, and yields a full inhibition of the NLC and eM at 1 mM in the –100 to
+ 160 mV voltage-range (Fig 2B and 2D). The dose-dependent inhibition of prestin by DFL is
further observed on the charge-transfer during hyperpolarizing voltage ramps (Fig 3E and 3F).
The maximum transfer significantly decreases with the DFL concentration, more so in low
intracellular-chloride conditions.
Due to the asymmetry of the NLC, the dataset was fitted using the two-state CSA model
equation (Eq 2) [29]. In the presence of DFL, fits obtained using the two-Boltzmann function
yielded an average root mean square error (RMSE) of 0.16 (± 0.07), while fitting with the CSA
model yielded a RMSE of 0.11 (± 0.06). The difference between the two fits was more apparent
as the asymmetry of the NLC was reinforced in the presence of DFL. The presence of the extra
component that tracks changes in specific membrane capacitance (CSA), fit the data more
accurately, notably in hyperpolarizing conditions. Modifications in the rate of the charge
Fig 1. Effect of diflunisal on the NLC in HEKs expressing prestin. (A) Representative non-linear
capacitance curves recorded on the same HEK cell expressing prestin, with () or without (●) DFL. (B).
Representative effect of DFL on the capacitance vs. voltage curve in the absence of prestin in HEKs. The
membrane capacitance CM of non-transfected HEKs was monitored at voltages from– 160 mV to +160 mV in
the absence and presence of DFL. (C) Effect of DFL on the membrane capacitance in the presence (Clin) and
absence (CM) of prestin. Both Clin and CM were obtained from fits to the capacitance vs. voltage curves, using
Eq 1 or a linear curve respectively. N = 4 for each condition. The error bars show the standard deviation. (D)
Fold increase for each parameter obtained from fitting the NLCs to Eq 1; n3 cells for each condition. The
error bar shows the standard deviation. The t-test is conducted between the values obtained upon perfusion
of ECB with DFL versus ECB alone: * p<0.01; ** p<0.001.
https://doi.org/10.1371/journal.pone.0183046.g001
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Fig 2. Effect of DFL on OHCs. The curves in A, C, E and in B, D F respectively are recorded on the same cells and in the
same conditions, during hyperpolarizing voltage ramps. (A) & (B) Representative NLCs recorded on 2 different OHCs
respectively with 140 mM and 5 mM chloride intracellularly. Increasing concentrations of DFL are perfused in the
chamber, from 10−4 mM to 1 mM. The fits of the two-state CSA model equation to the NLCs are shown as solid lines. In the
absence of drug, the average parameters are: Clin = 5.70±0.67 pF; Cmax = 9.54±1.01 pF; Qmax = 0.47±0.07 pC; V1/2 =
-42.4±12.9 mV; z = 0.84±0.4. (C) & (D) Cell length recorded concomitantly in μm. The solid lines are the resulting fits of
the data to the two-state CSA model equation (Eq 2). In the absence of drug, the average characteristics of eM are L0 =
18±2.4 μm; Lmax = 0.60±0.15 μm; V1/2 = -38.90±15.31 mV; α = -31.55±3.99 V-1. (E) & (F) Charge transfer against voltage,
obtained from Q = Σ(ΔV.C). (G) The voltage sensitivity (α = ze/kT) for charge transfer and eM is determined at peak
voltage and plotted against the DFL concentration. Each data point represents the average value from recordings on 3
cells or more, and the error bars are the standard deviation.
https://doi.org/10.1371/journal.pone.0183046.g002
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movement and of the eM are evident and are extracted from the fit as α = ze/kT, also referred
to as the voltage sensitivity. The resulting values are plotted in Fig 2G for each chloride
condition.
A significant drop in the voltage sensitivity exists for both eM and NLC at DFL concentra-
tions above 0.01 mM in low chloride conditions. At 0.2 mM DFL, the charge transfer rate
drops to 28.9±2.3 V-1 for the NLC (from 33±1.2 V-1 w/o DFL) and to 25.32±4.3 V-1 for the eM
(from 31.8±2.8 V-1 w/o DFL). Such a change in voltage sensitivity of the charge transfer has
been reported in the presence of 10 mM salicylate, from 32.5 V-1 to 17.25 V-1 for guinea pig
OHCs [29]. The parameters of the NLC and the eM affected by DFL in high (140 mM) and
low (5 mM) intracellular chloride conditions were determined next. V1/2 was calculated for
eM and NLC for each condition, and plotted against the concentration of DFL (Fig 3A). At
140 mM chloride, the shift in eM and NLC are similar, and significant at 0.1 mM DFL and
above. The shift is significant at 0.05 mM DFL and above when in low chloride conditions,
and is stronger for the eM than for the NLC. Such disparity between the V1/2(eM) and the V1/
2(NLC) has previously been reported for low chloride conditions [33]. Notably, this disparity
is amplified by the presence of DFL (Fig 3B). As described in the HEK cell model, the maxi-
mum non-linear charge movement Qmax decreases, in a DFL dose dependent manner, starting
at concentrations as low as 0.01mM DFL (Figs 2E, 2F and 3C). The inhibition is greater at
lower chloride concentrations, which approximate the in vivo condition [9]. In high and low
chloride conditions, respectively, Qmax was decreased to 38% (1 mM) and 29% (0.5 mM) of
the values recorded in the absence of DFL. Above these concentrations, the NLC could not be
fitted accurately. These inhibition curves were fitted to a Hill equation to produce apparent
IC50 of 331 μM and 98 μM in high and low chloride conditions, respectively (with Hill coeffi-
cient of -0.66 and -1.12, respectively).
The amplitude of the eM (plotted as % change in total cell length; Fig 3D), evidently result-
ing from the charge movement, is only inhibited at 0.5 mM DFL in low chloride conditions
(p<0.01) and has an apparent full inhibition at 1mM (within the tested voltage range), which
approximates the absence of NLC illustrated in Fig 2B. There was no significant decrease in
eM amplitude at any concentrations at high chloride conditions. An identical disparity be-
tween the maximal charge movement Qmax and the maximal amplitude of the cell movement
eMmax had been reported for decreased chloride concentrations [33], giving support to the
meno presto model to explain the kinetic behavior of prestin. The full eM inhibition observed
in the tested voltage-range at low chloride concentration and in the presence of 1mM DFL
(Fig 2D) did not fit Eq 3. Therefore, the data point (star in Fig 3D) is calculated as the length
change observed between the depolarized and hyperpolarized states in the voltage range, and
not from a plateaued state (as observed in Fig 2D at 1 mM DFL).
The expanded OHC total length LOHC also increases up to 8% with 1 mM DFL (Fig 4C).
The effect is similar at high and low chloride concentrations, suggesting that it results from the
partition of DFL in the membrane and not from the interaction with prestin. However, there
is no linear correlation between the NLC parameter Clin and the increase in LOHC. The 8%
change in cell length corresponds to an increase of ~40% in Clin (Fig 4A). The specific capaci-
tance for the OHCs was determined for each cell and condition as Clin/A (pF/μm2), where the
area A was calculated using the compacted length of the OHC and the diameter at the nucleus
level. Histograms of the specific capacitance as well as the probability distribution fitting to the
corresponding raw data are plotted in Fig 4D [34]. We regrouped the cells into three groups
based on the impact of DFL on Clin and cell length (Fig 4A–4C): no DFL; [DFL]≦10−2 mM
where neither Clin or length are modified and [DFL]>10
−2 mM where Clin and cell length are
significantly altered. The data obtained in the presence of 1mM DFL were not used since pre-
cise Clin were difficult to obtain. The specific capacitance increases in the presence of DFL
Diflunisal inhibits prestin
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Fig 3. NLC and eM in the presence of DFL and in different chloride conditions. (A) V1/2 value obtained
with OHCs from two-state Boltzmann fits of the NLC ( at low & ● at high intracellular chloride) and the eM ( 
at low & ■ at high intracellular chloride), plotted against DFL concentration. (B) The difference V1/2(NLC)—
V1/2(eM) shows decoupling between charge transfer and electromotility as [DFL] increases. The t-test is conducted
between the values obtained without DFL versus with DFL * p<0.01; ** p<0.001. (C) Inhibition of the NLC and
(D) of the eM by DFL. The dotted line is the resulting fit of the data by a Hill equation (140mM Cl: nH = -0.66,
IC50 = 331 μM; 5mM Cl-: nH = -1.12, IC50 = 98 μM), The resulting eM is only inhibited at concentrations above
0.5 mM in low chloride conditions. The value for eM at 1mM DFL at low chloride concentration was obtained from
direct measurement of cell length at hyperpolarized and depolarized voltages (star). For all plots, the data points
represent the average and the error bar is the standard deviation for n3 cells per condition.
https://doi.org/10.1371/journal.pone.0183046.g003
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from 9.45 fF/μm2 to 10.97 fF/μm2, whereas, the low DFL concentrations had no significant
impact (9.68 fF/μm2). These values are comparable to the specific capacitance of 10±1.7 fF/
μm2 reported for guinea pig OHCs [34].
Finally, we observed modifications of CSA (Fig 4E), the membrane specific capacitance,
which has been associated with changes in surface area during eM [8,29,33]. We investigated
the effect of DFL on ΔCSA (which is the change in capacitance, in regard to Clin) that occurs
when prestin goes from a compacted (depolarized) to expanded (hyperpolarized) state. The
behavior of ΔCSA is independent of the chloride concentration. In the absence of DFL, ΔCSA =
0.59 ± 0.24 pF (5 mM Cl-) and 0.64 ± 0.22 pF (140 mM Cl-). Since the number of motors in the
membrane is N = Qmax/z.e, the normalized corresponding value for each motor δCSA is ΔCSA.
z.e/Qmax, i.e. 151±62 zF and 191±55 zF in the absence of DFL at 5 mM and 140 mM chloride,
respectively. The resulting values are plotted against the DFL concentration in Fig 4F. At lower
concentrations, δCSA is not affected, but it decreases at concentrations above 10
−2 mM, and
reaches negative values. Such a drop in δCSA is also observed with increasing concentrations of
salicylate, but does not go lower than the value measured in the absence of drug [8]. However,
the effect of salicylate was not accompanied by such an increase in Clin. If the value of CSA mea-
sured at hyperpolarized voltages (Clin- ΔCSA) is plotted against the concentration of DFL we
observe a slight increase of CSA at inhibiting concentrations of DFL in low chloride conditions
(Fig 4E). The constant CSA at lower DFL concentration implies that the prestin-area related
capacitance is not affected. The capacitance vs voltage data for 0.5 and 1 mM DFL at 5mM
chloride could not be fitted to the two-state CSA model equation, due to the shift of the NLC
and the full inhibition of the NLC.
Discussion
Diflunisal inhibition compared to other prestin modulators
Diflunisal is an inhibitor of the prestin NLC at low intracellular chloride (1mM DFL, 5mM Cl-)
and results in the disruption of OHCs electromotility. Sub-inhibiting concentrations of DFL
(< 0.5mM) affects the charge transfer properties of prestin, lowering the Qmax and shifting V1/2,
without diminishing the amplitude of electromotility. This decoupling between electromotility
and charge transfer which has been described at low chloride concentrations, and described by
the meno presto model, is amplified here by DFL [33]. In the meno presto kinetic model, which
integrates the two-state CSA model used in our analysis, the presence of slow intermediate steps
between chloride binding and the two-state Boltzmann voltage-dependent process predict a
chloride-dependent disparity between the charge movement and the motor activity of prestin.
The differences between the V1/2 values (Fig 3B) or between the amplitudes (Qmax vs. Lmax; Fig
3C and 3D) observed in the presence of DFL are compatible with this model and with a direct
competition of DFL with chloride [32,33]. Moreover, the effect of DFL on the membrane high-
light that even when elongated by ~5% (4.9±1.3% and 4.6±3.1% in high and low chloride condi-
tions, respectively; Fig 4C) the OHCs are still able to yield an electromotive response with an
amplitude > 3% (3.5±1.4% and 3.1±0.8% at high and low chloride, respectively; Fig 3D).
Prestin can also be inhibited by increased membrane tension, increased temperature and
by application of salicylate. DFL induces a simultaneous decrease of Qmax and a positive shift
of V1/2, which is similar to the impact of increased membrane tension [13,35] and increased
temperature [12]. This dual impact is also observed when intracellular chloride is decreased
[36], hinting at the possibility that DFL could be competing with chloride ions. This is further
supported by the chloride-dependency of this inhibition, with DFL having a stronger effect at
low chloride concentrations. As reported for salicylate, this suggests that DFL competes with
chloride ions [4,9], or modifies the interaction of prestin with chloride, which is essential for
Diflunisal inhibits prestin
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prestin function (as discussed in [7]). The effect of DFL is comparable to the effect of salicylate
at 5 mM chloride (IC50SAL = 79.8 μM on guinea pig OHC vs IC50DFL = 98 μM), but is greater at
140 mM chloride (IC50SAL = 964 μM on guinea pig OHC IC50DFL = 331 μM)[9]. If we consider
a competitive inhibition mechanism, DFL is more able to displace Cl- ions than salicylate and
therefore has a lower Ki. This is surprising, considering both molecules have the same single
negative charge, but that DFL has an extra aromatic ring. The greater steric occupancy of diflu-
nisal (198 Å3 van der Waals volume vs. 118Å3 for salicylate [30]) should impair access to the
binding site. This implies that the binding site for chloride, and salicylate and DFL, is not
restrictive but accessible to larger molecules.
Finally, the blood-cochlear barrier is physiologically similar to the blood-brain barrier [37],
and DFL, like salicylate, has a polar surface area (PSA = 60.4 A2) low enough to allow these
Fig 4. DFL affects the capacitance and the length of the OHC. (A) The effect of DFL on absolute Clin and Cmax values and (B) relative
Clin (compiled on a cell to cell basis) are compared to (C) the change in total cell length, plotted as the ratio of OHC length with DFL to
without. In order to have reliable data at high DFL concentrations, we used the fully extended length to calculate this ratio. (D) Specific
capacitance Clin/A (pF/μm2) is calculated for each OHC and showed in 3 distribution histograms. The diameter and length of each cell was
measured and the resulting area was determined. Low DFL: [DFL]10−2 mM & High DFL: [DFL]>10−2 mM. The averages obtained from the
probability distribution fitting of the raw data (grey line) are 9.45±1.9, 9.68±1.7 and 10.97±2.1 fF/μm2. (E) The surface area specific
capacitance CSA as well as (F) the difference between CSA and Clin (ΔCSA) are obtained from fitting the NLCs. ΔCSA is normalized by
dividing by the number of active motors N in the absence of drug on a cell to cell basis. Each value is averaged from 3 independent
recordings or more, and the error bars represent the standard deviation. (t-test: * p<0.01; ** p<0.001).
https://doi.org/10.1371/journal.pone.0183046.g004
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molecules to penetrate the blood-cochlear barrier [38,39]. Therefore, the effect of diflunisal on
isolated OHCs can have physiological consequences similar to the salicylate effect on tinnitus
[40].
Diflunisal effects on the lipid bilayer
DFL provokes a chloride-independent increase in membrane surface area and specific capaci-
tance greater than that observed for salicylate (Fig 4). This substantial effect of DFL on mem-
brane properties is consistent with a higher affinity of DFL for a hydrophobic environment,
and is accompanied by a chloride-independent increase in Clin. The interaction of DFL with
the membrane is illustrated by the dramatic increase in OHC area (35.9 ± 17.7, 54.6 ± 17.4 and
53.3 ± 29.7 μm2 for 0.2, 0.5 and 1.0 mM DFL, respectively). Assuming a steric effect, and con-
sidering a projection area between 33.8 and 70.6 Å2 for DFL [30], the area change corresponds
to the partition of 7.8x106 to 16.5x106 molecules of DFL in the membrane at 0.5mM DFL. This
is more than the ~4x106 DFL molecules predicted by the logDDFL of 0.41 [30], suggesting that
the elongation of the OHC by DFL is not solely due to the spatial occupancy of DFL in the
membrane. The OHC lateral wall is constituted of a corrugated plasma membrane [41–45]
which is modeled to anchor to the cytoskeleton at regular intervals [46]. Modifications of the
curvature of this local bending of the membrane have significant impact on prestin. The
amphipaths CPZ+ and TNP- localize to the inner and outer leaflet to cause local inward and
outward bending of these corrugations, respectively, and both result in a depolarized shift of
the NLC [11,17,18,47]. Similarly, the preferential partitioning of DFL- in the outer or inner
leaflet of the membrane could modify the radius of the local membrane curvature and in turn
further affect the apparent OHC length as well as V1/2.
Moreover, the presence of DFL in the membrane increases the specific membrane capaci-
tance from 9.45 to 10.97 fF/μm2 (Fig 4D), suggesting an additional effect of DFL on the electri-
cal properties of the membrane. Membrane capacitance depends on the membrane area (A),
the membrane thickness (d) and the dielectric constant of the membrane (ε) where Cm = ε.A/d
[48]. Consequently, the increase of the specific membrane capacitance demonstrates a decrease
in membrane thickness d or an increase of the membrane dielectric constant ε or both. Inter-
estingly, changes in membrane thickness have also shown to impact prestin. Decreasing mem-
brane thickness by adding PC12:0 increases Clin by 20% and shifts V1/2 to depolarized values.
However, no change in Qmax has been observed upon decrease in membrane thickness [49].
DFL might therefore have two effects: (i) it impacts Clin and V1/2 when partitioning in the
membrane (see Fig 3A, the shift in NLC is not dependent on chloride concentration), and (ii)
it inhibits charge transfer when interacting with prestin.
Diflunisal affects OHCs and HEKs differently
The effects of DFL on the NLC and on CM are more effective in native OHCs than in HEKs.
At 0.1 mM DFL in HEK, prestin is barely affected, with V1/2 shifting 1.4 mV and Qmax drop-
ping by 10%, while at the same 0.1 mM DFL in OHC, the V1/2 shifts 18 mV and Qmax is low-
ered by 25%. Such a difference is observable for all concentrations tested on both HEKs and
OHCs (<1 mM). Salicylate is also more effective on OHCs, compared to HEKs expressing
prestin. The IC50s estimated from published data with OHCs [50] and HEKs expressing rat
prestin[4] were 220 μM and 640 μM, respectively, both with 140 mM intracellular chloride. In
our experiments, for the same conditions, the apparent IC50 from a Hill fit to Qmax vs. [DFL] is
331μM for OHCs and 2.76 mM for HEKs at 140 mM intracellular chloride. Finally, the effect
on membrane capacitance is more pronounced in OHCs than in HEKs, with an increase of
Clin by 2% in HEKs vs. 22% in OHCs at 0.1 mM DFL (and 5% vs. 40% at 1 mM DFL). The
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different lipid compositions in OHCs and HEKs can alter the interaction of the negatively
charged DFL with the membrane and the subsequent partitioning of the molecules. Moreover,
the density of prestin in the OHC membrane is very high and therefore has an impact on the
dielectric constant [51] and the fluidity of the membrane, which could be affected differently
by DFL. Importantly, the strong and specific interaction of DFL with hearing cells will lead to
more specific damage to the cochlea.
Diflunisal and the surface area capacitance CSA
DFL has a greater effect on Clin than on the surface area capacitance measured at hyperpolar-
ized voltages (CSA). CSA illustrates the increase in membrane capacitance due to the change in
prestin-dependent membrane surface area, and not to the charge transfer. The increase in CSA
observed at inhibiting conditions (Fig 4E) is consistent with prestin being maintained in an
expanded state in the presence of DFL, similarly to what has been reported for salicylate [8].
Similarly, the drop in δCSA (Fig 4F) reflects the decrease in the number of functional motors
due to the presence of the inhibitor, as reported for salicylate ([32]).
The value of the CSA / area (A) relationship does not significantly change in the absence
(8.8±1.8 fF/μm2) and presence (9.82 ±1.5 fF/μm2) of DFL (data determined for CSA/A as for
Clin/A in Fig 4D). Even when the NLC is inhibited at 1 mM DFL in low chloride conditions,
the measured specific CSA is 10.9±2.2 fF/μm2 (n = 4). This discrepancy between the capaci-
tance at depolarizing and hyperpolarizing membrane potentials could stem from a voltage
dependent repositioning of the charged DFL- molecule in the membrane, resulting in a
decrease of d or an increase of ε at depolarizing but not hyperpolarizing potentials. DFL
showed no voltage-dependent effect on the capacitance of HEKs without prestin, implying
that either prestin or the OHC corrugations are necessary for these DFL-induced membrane
modifications.
Conclusion
Although diflunisal is a commonly used NSAID, the specific effects of diflunisal on hearing
have not been well studied. We have investigated how diflunisal affects the function of outer
hair cells and its effect on the motor protein prestin. Despite being a derivative of salicylate
with identical charge, diflunisal has a lower IC50 at high chloride concentration and a similar
one at low chloride concentration. It triggers a greater elongation of the OHC and initiates a
greater increase in membrane capacitance (Clin and CSA) than does salicylate. Notably, this
study revealed clues about the biophysical mechanisms of action on prestin. We demonstrate
that the impact of diflunisal on prestin involves a dual mechanism: (i) diflunisal directly inter-
acts with prestin through competition with chloride ions and (ii) modifies the properties of the
membrane, which in turn affect the NLC [4,7,11]. Consequently, if the competition with chlo-
ride is specific to prestin, DFL might affect other mechano-sensitive membrane proteins
through alteration of membrane material properties [26].
Finally, diflunisal has promising therapeutic properties–in preventing the formation of
amyloid fibrils [26], as an anti-tumor agent against cancerous cell growth [52], and as an osteo-
protectant in Staphylococcus aureus-induced osteomyelitis [53]. These recent attempts to
repurpose diflunisal highlights the necessity to further investigate the impact of this molecule
on hearing to understand the potential of irreversible side effects.
Supporting information
S1 Fig. Perfusion control—In order to test the effect of perfusion alone, and to control the
impact of extra Na+ and Cl- that are added with some NSAIDs salts, NLCs were recorded
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on HEKs expressing prestin before and after the perfusion of regular ECB (clear bars) or
ECB containing 109 mM NaCl (i.e. 10 mM extra NaCl–dark bars). The bars show the aver-
age change for each parameter ± standard deviation. No statistically significant difference is
observed.
(TIF)
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